182 related articles for article (PubMed ID: 28332502)
1. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.
Dienstmann R; Vermeulen L; Guinney J; Kopetz S; Tejpar S; Tabernero J
Nat Rev Cancer; 2017 Mar; 17(4):268. PubMed ID: 28332502
[No Abstract] [Full Text] [Related]
2. Biomarkers in Colorectal Cancer.
Yiu AJ; Yiu CY
Anticancer Res; 2016 Mar; 36(3):1093-102. PubMed ID: 26977004
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
4. Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.
Chen G; Yang Z; Eshleman JR; Netto GJ; Lin MT
Biomed Res Int; 2016; 2016():9850690. PubMed ID: 27699178
[TBL] [Abstract][Full Text] [Related]
5. Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.
Sinicrope FA; Okamoto K; Kasi PM; Kawakami H
Clin Gastroenterol Hepatol; 2016 May; 14(5):651-8. PubMed ID: 26872400
[TBL] [Abstract][Full Text] [Related]
6. Current and future biomarkers in the treatment of colorectal cancer.
Cuyle PJ; Prenen H
Acta Clin Belg; 2017 Apr; 72(2):103-115. PubMed ID: 27917697
[TBL] [Abstract][Full Text] [Related]
7. Reclassifying colorectal cancer subtypes.
Burki TK
Lancet Oncol; 2015 Dec; 16(16):e591. PubMed ID: 26511645
[No Abstract] [Full Text] [Related]
8. The landscape of precision cancer medicine clinical trials in the United States.
Roper N; Stensland KD; Hendricks R; Galsky MD
Cancer Treat Rev; 2015 May; 41(5):385-90. PubMed ID: 25864024
[TBL] [Abstract][Full Text] [Related]
9. Cancer classification in the genomic era: five contemporary problems.
Song Q; Merajver SD; Li JZ
Hum Genomics; 2015 Oct; 9():27. PubMed ID: 26481255
[TBL] [Abstract][Full Text] [Related]
10. Molecular Profiles Guide Colorectal Cancer Treatment.
Kratz JD; Turk AA; Sievers CK; Clipson L; Matkowskyj KA; Deming DA
Fed Pract; 2016 May; 33(Suppl 4):50S-53S. PubMed ID: 30766219
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach.
Blanco-Calvo M; Concha Á; Figueroa A; Garrido F; Valladares-Ayerbes M
Int J Mol Sci; 2015 Jun; 16(6):13610-32. PubMed ID: 26084042
[TBL] [Abstract][Full Text] [Related]
12. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Choi YY; Cheong JH
Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
[TBL] [Abstract][Full Text] [Related]
13. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic cancer subtypes--next steps into personalized medicine.
Santos C; Sanz-Pamplona R; Nadal E; Grasselli J; Pernas S; Dienstmann R; Moreno V; Tabernero J; Salazar R
Cell Oncol (Dordr); 2015 Feb; 38(1):3-16. PubMed ID: 25586691
[TBL] [Abstract][Full Text] [Related]
15. [Development of indicators to evaluate colorectal cancer prevention programs in the high-risk population: the experience of a high-risk colorectal cancer clinic].
Serra Sutton V; Espallargues M; Balaguer F; Castells A
Gastroenterol Hepatol; 2012 Nov; 35(9):613-24. PubMed ID: 22749512
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer subtypes: Translation to routine clinical pathology.
Roseweir AK; McMillan DC; Horgan PG; Edwards J
Cancer Treat Rev; 2017 Jun; 57():1-7. PubMed ID: 28505475
[TBL] [Abstract][Full Text] [Related]
18. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
19. Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.
Tian H; Zhou C; Yang J; Li J; Gong Z
Tumour Biol; 2017 Apr; 39(4):1010428317697578. PubMed ID: 28381159
[TBL] [Abstract][Full Text] [Related]
20. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
Do K; O'Sullivan Coyne G; Chen AP
Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
